RPTIX
Price
$113.32
Change
-$0.78 (-0.68%)
Updated
Nov 12 closing price
THCRX
Price
$31.25
Change
-$0.50 (-1.57%)
Updated
Nov 12 closing price
Ad is loading...

RPTIX vs THCRX

Header iconRPTIX vs THCRX Comparison
Open Charts RPTIX vs THCRXBanner chart's image
T. Rowe Price Mid-Cap Growth I
Price$113.32
Change-$0.78 (-0.68%)
VolumeN/A
CapitalizationN/A
Thornburg Small/Mid Cap Growth R3
Price$31.25
Change-$0.50 (-1.57%)
VolumeN/A
CapitalizationN/A
RPTIX vs THCRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RPTIX vs. THCRX commentary
Nov 13, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RPTIX is a Buy and THCRX is a Buy.

FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 32.3B vs. THCRX (291M). RPTIX pays higher dividends than THCRX: RPTIX (0.18) vs THCRX (0.00). RPTIX was incepted earlier than THCRX: RPTIX (9 years) vs THCRX (21 years). THCRX is a more actively managed with annual turnover of: 57.56 vs. RPTIX (21.70). THCRX has a lower initial minimum investment than RPTIX: THCRX (0) vs RPTIX (500000). THCRX annual gain was more profitable for investors over the last year : 38.83 vs. RPTIX (21.29). RPTIX return over 5 years is better than : 18.66 vs. THCRX (-14.57).
RPTIXTHCRXRPTIX / THCRX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years21 years-
Gain YTD13.03722.79057%
Front LoadN/AN/A-
Min. Initial Investment5000000-
Min. Initial Investment IRAN/AN/A-
Net Assets32.3B291M11,100%
Annual Yield % from dividends0.180.00-
Returns for 1 year21.2938.8355%
Returns for 3 years-14.64-42.6834%
Returns for 5 years18.66-14.57-128%
Returns for 10 yearsN/A14.09-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNMD74.77-0.09
-0.12%
CONMED Corp
DOX92.71-0.15
-0.16%
Amdocs Limited
TERN7.17-0.29
-3.89%
Terns Pharmaceuticals
AUUD0.57-0.06
-8.93%
Auddia
EBS10.89-1.08
-9.02%
Emergent Biosolutions